Mansonellosis, also known as mansonellosis, is a parasitic disease caused by nematodes of the genus Mansonella, which are transmitted through insect bites. There are different species of the causative agent, the most well-known of which are Mansonella ozzardi and Mansonella perstans. The disease is characterized by a chronic course and a variety of clinical manifestations, including dermatological reactions, arthralgia, lymphadenopathy and, in rare cases, involvement of internal organs. Since many patients may not be correctly diagnosed for months or even years, mansonellosis remains a significant problem in areas where it is endemic, particularly in tropical and subtropical zones.
History of the disease and interesting historical facts
Mansonellosis was first described in 1897 by the American physician J. N. Munson, after which it was given its current generic name. Mansonellosis was studied mainly in the context of its prevalence in West Africa and Central and South America. In the 1920s, it was established that the disease was transmitted through fly bites. Numerous studies conducted in the 1960s and 1970s allowed a better understanding of the incidence and life of the parasite. Since then, a significant database has been accumulated on the prevalence of mansonellosis, its symptoms and possible treatment, but research into the disease continues today.
Epidemiology
According to the World Health Organization, mansonellosis is endemic in certain areas of Africa, Central and South America, and some Asian countries. Estimates of the incidence vary, but recent studies estimate that there are more than 25 million cases of mansonellosis worldwide, with the highest concentrations in countries such as Brazil and Colombia. The ability to accurately diagnose and identify the number of infected individuals remains limited, as not all patients seek medical care and not all cases are reported. It is known that the disease most often affects people working in agriculture, who have an increased risk of exposure to insect vectors.
Genetic predisposition to this disease
To date, studies have shown that genetic predisposition to mansonellosis is still insufficient. While the literature on other parasitic diseases such as malaria or leishmaniasis includes information on the involvement of certain genes such as HLA and their association with a protective effect, for mansonellosis such data are virtually non-existent. There are cases where differences in the immune response of individuals may be influenced by genetic factors, but the precise mechanisms remain unclear. It is likely that unique characteristics of local populations in endemic areas, such as the degree of induced susceptibility to infections, also play a role in the spread and duration of the disease.
Risk factors for the development of this disease
There are several risk factors that contribute to the development of mansonellosis:
- Ecological: the presence of water bodies where moss-carriers live;
- Professional: outdoor work, especially in agriculture;
- Genetic: individual predisposition and characteristics of the immune response;
- Social: living conditions and inadequate access to sanitation and health care;
- Geographic: regions with high humidity and favorable conditions for the habitation of insect vectors.
Diagnosis of this disease
Diagnosis of mansonellosis can be challenging, as clinical symptoms are often non-specific. The main symptoms include inflammation of the lymph nodes, pruritus and rash on the skin, arthralgias and possible neurological disorders. Laboratory investigations usually include serologic tests for antibodies to the parasite, and microscopic examination of skin and lymph swabs for larvae. Radiological investigations, such as ultrasound or CT of organs, may be necessary in cases of complex symptoms when there is a suspicion of internal organ involvement. The differential diagnosis includes exclusion of other parasitic and infectious diseases, such as leishmaniasis, tropical syndromic form and lymphogranulomatosis, which can present with similar symptoms.
Treatment
Treatment of mansonellosis does not have a universal approach and depends on the severity of the symptoms. General recommendations include the use of anthelmintic drugs such as Ivekas. Pharmacological treatment mainly involves the administration of microscopic doses of ivemectin, which has proven to be effective against nematodes. In cases of severe symptoms, surgery may be required to remove abscesses or lymphatic drainage. Other treatments are aimed at relieving symptoms, such as the use of antihistamines to eliminate itching and inflammation. It is also important to carry out supportive therapy to restore the general condition.
List of medications used to treat this disease
- Ivemectin;
- Decaris (levamisole);
- Albendazole;
- Antihistamines (for symptomatic treatment);
- Nonsteroidal anti-inflammatory drugs (for pain and inflammation).
Disease monitoring
Monitoring the patient's condition with mansonellosis includes regular follow-up examinations aimed at assessing the dynamics of clinical symptoms and response to treatment. The prognosis of the disease is generally favorable, but in case of late diagnosis and lack of treatment, complications are possible, including chronic inflammatory processes and the development of lymphedema. Thus, early detection and adequate treatment play a key role in improving the patient's quality of life.
Age-related features of the disease
Mansonellosis can affect people of all ages, but adults, especially men, are most often infected due to their greater activity outdoors. In children, clinical manifestations may be less pronounced, but infections have also been reported. Conditions such as skin hypersensitivity may be more pronounced in childhood, while older patients are at increased risk of complications due to underlying medical conditions and a weakened immune system.
Questions and Answers
- How is mansonellosis transmitted? Mansonellosis is transmitted through the bite of insects, most often through flies and mosquitoes.
- What are the main symptoms of mansonellosis? The main symptoms include itching, skin rashes, joint pain and swollen lymph nodes.
- How is mansonellosis diagnosed? Diagnosis includes clinical examination, laboratory tests for antibodies and larvae, and possibly radiological examination.
- What treatment is prescribed for mansonellosis? Treatment involves administration of ivemectin and other anthelmintic drugs, as well as supportive care to relieve symptoms.
- What is the prognosis and possible complications of mansonellosis? The prognosis is favorable in most cases with timely diagnosis and treatment, but complications such as lymphedema and chronic inflammation are possible.
